Cash flow Dow Inc.

Equities

DOW

US2605571031

Commodity Chemicals

Delayed Nyse Other stock markets 21:00:02 16/01/2026 GMT			5-day change	1st Jan Change
27.57 ^USD	-1.32%		+4.71%	+17.92%

01-16	Westlake Poised for Upside Despite Weak Chemical Demand, RBC Says	MT
01-16	RBC Adjusts Price Target on Dow to $29 From $25, Maintains Sector Perform Rating	MT

94cad5fc.JwxMk1znOPb14pidoAYmKpFNsKImoPzPL2GL4ZZ8v6k.YDsdxDiDUIDCsP3k2TFrU9guyMRj2c77RFDph-4K7u8VbQv2LdBzrMGk0Q

Published financial data: DOW INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	38.54B	54.97B	56.9B	44.62B	42.96B
Total Revenues	38.54B	54.97B	56.9B	44.62B	42.96B
Cost of Goods Sold, Total	33.36B	44.19B	48.34B	39.56B	38.28B
Gross Profit	5.18B	10.78B	8.56B	5.06B	4.68B
Selling General & Admin Expenses, Total	1.37B	1.31B	1.32B	1.27B	1.32B
R&D Expenses	768M	857M	851M	829M	810M
Amortization of Goodwill and Intangible Assets - (IS)	401M	388M	336M	324M	310M
Other Operating Expenses, Total	2.54B	2.56B	2.5B	2.42B	2.44B
Operating Income	2.65B	8.22B	6.06B	2.64B	2.24B
Interest Expense, Total	-827M	-731M	-662M	-746M	-811M
Interest And Investment Income	38M	55M	173M	229M	200M
Net Interest Expenses	-789M	-676M	-489M	-517M	-611M
Income (Loss) On Equity Invest.	-18M	975M	268M	-119M	-6M
Currency Exchange Gains (Loss)	-62M	-8M	-117M	-340M	-45M
Other Non Operating Income (Expenses)	84M	10M	31M	125M	100M
EBT, Excl. Unusual Items	1.86B	8.52B	5.75B	1.78B	1.68B
Restructuring Charges	-562M	-12M	-	-528M	-103M
Merger & Related Restructuring Charges	-239M	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-18M	18M
Gain (Loss) On Sale Of Assets	765M	121M	78M	80M	60M
Asset Writedown	-135M	6M	-	-	-
Legal Settlements	549M	54M	381M	-51M	-
Other Unusual Items	-170M	-544M	-122M	-611M	-57M
EBT, Incl. Unusual Items	2.07B	8.14B	6.09B	656M	1.6B
Income Tax Expense	777M	1.74B	1.45B	-4M	399M
Earnings From Continuing Operations	1.29B	6.4B	4.64B	660M	1.2B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	1.29B	6.4B	4.64B	660M	1.2B
Minority Interest	-69M	-94M	-58M	-71M	-85M
Net Income - (IS)	1.22B	6.31B	4.58B	589M	1.12B
Preferred Dividend and Other Adjustments	9M	32M	24M	11M	12M
Net Income to Common Incl Extra Items	1.22B	6.28B	4.56B	578M	1.1B
Net Income to Common Excl. Extra Items	1.22B	6.28B	4.56B	578M	1.1B
Per Share Items
Net EPS - Basic	1.64	8.44	6.32	0.82	1.57
Basic EPS - Continuing Operations	1.64	8.44	6.32	0.82	1.57
Basic Weighted Average Shares Outstanding	740M	744M	721M	706M	704M
Net EPS - Diluted	1.64	8.38	6.28	0.82	1.57
Diluted EPS - Continuing Operations	1.64	8.38	6.28	0.82	1.57
Diluted Weighted Average Shares Outstanding	742M	749M	726M	709M	705M
Normalized Basic EPS	1.48	7.03	4.91	1.48	1.37
Normalized Diluted EPS	1.48	6.98	4.88	1.47	1.37
Dividend Per Share	2.8	2.8	2.8	2.8	2.8
Payout Ratio	169.06	32.85	43.78	334.8	176.16
Supplemental Items
EBITDA	5.43B	10.97B	8.74B	5.18B	5.07B
EBITA	3.05B	8.61B	6.4B	2.96B	2.55B
EBIT	2.65B	8.22B	6.06B	2.64B	2.24B
EBITDAR	6.32B	12.08B	9.99B	6.78B	6.46B
Effective Tax Rate - (Ratio)	37.52	21.36	23.81	-0.61	24.94
Current Domestic Taxes	-172M	2M	516M	267M	-125M
Current Foreign Taxes	691M	1.46B	855M	951M	389M
Total Current Taxes	519M	1.46B	1.37B	1.22B	264M
Deferred Domestic Taxes	203M	156M	64M	-442M	269M
Deferred Foreign Taxes	55M	122M	15M	-780M	-134M
Total Deferred Taxes	258M	278M	79M	-1.22B	135M
Normalized Net Income	1.1B	5.23B	3.54B	1.04B	966M
Interest Capitalized	64M	59M	63M	88M	133M
Interest on Long-Term Debt	89M	86M	95M	122M	178M
Non-Cash Pension Expense	-128M	-348M	-369M	276M	-258M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	768M	857M	851M	829M	810M
Net Rental Expense, Total	891M	1.11B	1.25B	1.6B	1.39B
Imputed Operating Lease Interest Expense	329M	394M	441M	644M	613M
Imputed Operating Lease Depreciation	562M	713M	812M	957M	773M
Stock-Based Comp., Other (Total)	243M	353M	242M	212M	159M
Total Stock-Based Compensation	243M	353M	242M	212M	159M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	5.1B	2.99B	3.89B	2.99B	2.19B
Short Term Investments	45M	245M	939M	1.3B	383M
Trading Asset Securities, Total	-	1M	105M	1M	-
Total Cash And Short Term Investments	5.15B	3.23B	4.93B	4.29B	2.57B
Accounts Receivable, Total	4.9B	6.88B	5.66B	4.73B	4.76B
Other Receivables	261M	357M	307M	189M	300M
Notes Receivable	2.55B	2.36B	1.84B	1.71B	1.81B
Total Receivables	7.71B	9.59B	7.8B	6.63B	6.86B
Inventory	5.7B	7.37B	6.99B	6.08B	6.54B
Restricted Cash	4M	45M	54M	61M	74M
Other Current Assets, Total	521M	609M	702M	562M	536M
Total Current Assets	19.08B	20.85B	20.48B	17.61B	16.59B
Gross Property Plant And Equipment	58.18B	59.02B	59.28B	61.52B	63.39B
Accumulated Depreciation	-36.09B	-37.05B	-37.61B	-39.14B	-40.12B
Net Property Plant And Equipment	22.1B	21.97B	21.67B	22.39B	23.27B
Long-term Investments	4.61B	5.72B	5.05B	4.45B	4.68B
Goodwill	8.91B	8.76B	8.64B	8.64B	8.56B
Other Intangibles, Total	3.35B	2.88B	2.44B	2.07B	1.72B
Accounts Receivable Long-Term	11M	26M	16M	4M	2M
Deferred Tax Assets Long-Term	2.22B	1.36B	960M	1.49B	1.26B
Deferred Charges Long-Term	1.17B	1.4B	1.35B	421M	458M
Other Long-Term Assets, Total	23M	35M	-	895M	768M
Total Assets	61.47B	62.99B	60.6B	57.97B	57.31B
Liabilities
Accounts Payable, Total	5.89B	8.42B	7.22B	6.33B	6.54B
Accrued Expenses, Total	2.16B	2.46B	2.38B	2.34B	2.11B
Short-term Borrowings	156M	161M	362M	62M	135M
Current Portion of Long-Term Debt	410M	203M	253M	22M	418M
Current Portion of Leases	470M	420M	396M	446M	424M
Current Income Taxes Payable	397M	623M	334M	419M	276M
Unearned Revenue Current, Total	349M	209M	275M	195M	244M
Other Current Liabilities	1.28B	729M	113M	144M	140M
Total Current Liabilities	11.11B	13.23B	11.33B	9.96B	10.29B
Long-Term Debt	16.2B	13.58B	14.02B	14.15B	14.88B
Long-Term Leases	1.98B	1.91B	1.68B	1.79B	1.82B
Unearned Revenue Non Current	1.92B	1.92B	1.72B	1.64B	1.48B
Pension & Other Post Retirement Benefits	11.65B	7.56B	3.81B	4.93B	4.74B
Deferred Tax Liability Non Current	405M	506M	1.11B	399M	392M
Other Non Current Liabilities	5.2B	5.55B	5.69B	5.99B	5.87B
Total Liabilities	48.46B	44.25B	39.36B	38.86B	39.46B
Common Stock, Total	8M	8M	8M	8M	8M
Additional Paid In Capital	7.6B	8.15B	8.54B	8.88B	9.2B
Retained Earnings	16.36B	20.62B	23.18B	21.77B	20.91B
Treasury Stock	-625M	-1.62B	-3.87B	-4.37B	-4.66B
Comprehensive Income and Other	-10.9B	-8.99B	-7.14B	-7.68B	-8.11B
Total Common Equity	12.44B	18.16B	20.72B	18.61B	17.36B
Minority Interest	570M	574M	529M	501M	496M
Total Equity	13B	18.74B	21.25B	19.11B	17.85B
Total Liabilities And Equity	61.47B	62.99B	60.6B	57.97B	57.31B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	741M	731M	705M	702M	704M
ECS Total Common Shares Outstanding	741M	731M	705M	702M	704M
Book Value / Share	16.77	24.86	29.39	26.49	24.67
Tangible Book Value	175M	6.52B	9.63B	7.89B	7.07B
Tangible Book Value Per Share	0.24	8.92	13.66	11.24	10.05
Total Debt	19.23B	16.28B	16.71B	16.47B	17.67B
Net Debt	14.08B	13.04B	11.78B	12.18B	15.1B
Debt Equivalent of Unfunded Proj. Benefit Obligation	8.9B	4.81B	1.63B	2.83B	2.84B
Debt Equivalent Oper. Leases	7.13B	8.86B	10.02B	12.81B	11.09B
Minority Interest, Total (Incl. Fin. Div)	570M	574M	529M	501M	496M
Equity Method Investments, Total	1.33B	2.04B	1.59B	1.27B	1.27B
Account Code - Inventory Valuation	4	4	4	4	4
LIFO Reserve, Total	34M	-485M	-484M	-309M	-413M
Inventories - Raw Materials, Total	598M	822M	954M	746M	822M
Inventories - Work In Process, Total	996M	1.62B	1.48B	1.23B	1.32B
Inventories - Finished Goods, Total	3.14B	4.55B	4.15B	3.41B	3.77B
Inventories - Others	933M	866M	892M	992M	1.04B
Land - (BS)	2.01B	2.04B	2.13B	2.22B	2.26B
Buildings, Total	4.98B	5.11B	5.04B	5.22B	5.14B
Machinery, Total	42.11B	42.63B	42.13B	43.34B	44.05B
Full Time Employees	35.7K	35.7K	37.8K	35.9K	36K
Accumulated Allowance for Doubtful Accounts (Supple)	51M	54M	110M	81M	95M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	1.22B	6.31B	4.58B	589M	1.12B
Depreciation & Amortization - CF	2.38B	2.36B	2.34B	2.22B	2.52B
Amortization of Goodwill and Intangible Assets - (CF)	401M	388M	336M	324M	310M
Depreciation & Amortization, Total	2.78B	2.75B	2.68B	2.54B	2.83B
Amortization of Deferred Charges, Total - (CF)	96M	90M	80M	70M	67M
(Gain) Loss From Sale Of Asset	-484M	816M	193M	-70M	174M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	708M	6M	-	528M	103M
(Income) Loss On Equity Investments - (CF)	443M	-651M	696M	387M	348M
Net Cash From Discontinued Operations	-26M	-60M	-11M	32M	11M
Other Operating Activities, Total	294M	-808M	43M	51M	-111M
Change In Accounts Receivable	171M	-2.13B	1.19B	1.16B	-224M
Change In Inventories	515M	-1.77B	347M	844M	-529M
Change In Accounts Payable	-84M	2.46B	-1.26B	-734M	278M
Change in Other Net Operating Assets	590M	-5M	-1.06B	-203M	-1.15B
Cash from Operations	6.23B	7.01B	7.48B	5.2B	2.91B
Capital Expenditure	-1.39B	-2.42B	-2.25B	-2.69B	-3.27B
Sale of Property, Plant, and Equipment	929M	68M	32M	95M	234M
Investment in Marketable and Equity Securities, Total	-407M	-556M	-704M	-270M	699M
Other Investing Activities, Total	29M	-10M	-50M	-61M	-33M
Cash from Investing	-841M	-2.91B	-2.97B	-2.93B	-2.37B
Short Term Debt Issued, Total	163M	144M	253M	-	143M
Long-Term Debt Issued, Total	4.67B	109M	1.67B	104M	1.47B
Total Debt Issued	4.84B	253M	1.92B	104M	1.61B
Short Term Debt Repaid, Total	-594M	-178M	-14M	-249M	-78M
Long-Term Debt Repaid, Total	-4.65B	-2.77B	-1.01B	-446M	-267M
Total Debt Repaid	-5.25B	-2.95B	-1.02B	-695M	-345M
Issuance of Common Stock	108M	320M	212M	188M	166M
Repurchase of Common Stock	-152M	-1.01B	-2.36B	-667M	-533M
Common Dividends Paid	-2.07B	-2.07B	-2.01B	-1.97B	-1.97B
Common & Preferred Stock Dividends Paid	-2.07B	-2.07B	-2.01B	-1.97B	-1.97B
Other Financing Activities, Total	-237M	-610M	-107M	-73M	-100M
Cash from Financing	-2.76B	-6.07B	-3.36B	-3.12B	-1.17B
Foreign Exchange Rate Adjustments	107M	-99M	-237M	-45M	-163M
Miscellaneous Cash Flow Adjustments	-4M	-45M	-54M	-61M	-74M
Net Change in Cash	2.72B	-2.12B	853M	-953M	-859M
Supplemental Items
Cash Interest Paid	842M	801M	675M	800M	887M
Cash Income Tax Paid (Refund)	518M	731M	793M	735M	827M
Levered Free Cash Flow	4.31B	4.15B	4.07B	2.64B	-127M
Unlevered Free Cash Flow	4.83B	4.61B	4.48B	3.11B	380M
Change In Net Working Capital	-1.45B	1.31B	55M	-1.33B	808M
Net Debt Issued / Repaid	-412M	-2.7B	900M	-591M	1.26B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	2.71	8.25	6.13	2.78	2.43
Return on Total Capital	5.03	15.28	10.38	4.48	3.95
Return On Equity %	9.55	40.35	23.21	3.27	6.5
Return on Common Equity	9.36	41.04	23.44	2.94	6.14
Margin Analysis
Gross Profit Margin %	13.45	19.61	15.05	11.33	10.9
SG&A Margin	3.55	2.39	2.31	2.84	3.07
EBITDA Margin %	14.08	19.96	15.36	11.6	11.8
EBITA Margin %	7.91	15.66	11.24	6.63	5.94
EBIT Margin %	6.87	14.95	10.65	5.91	5.22
Income From Continuing Operations Margin %	3.36	11.65	8.15	1.48	2.8
Net Income Margin %	3.18	11.48	8.05	1.32	2.6
Net Avail. For Common Margin %	3.15	11.42	8.01	1.3	2.57
Normalized Net Income Margin	2.84	9.52	6.22	2.34	2.25
Levered Free Cash Flow Margin	11.19	7.55	7.15	5.92	-0.3
Unlevered Free Cash Flow Margin	12.53	8.38	7.88	6.96	0.88
Asset Turnover
Asset Turnover	0.63	0.88	0.92	0.75	0.75
Fixed Assets Turnover	1.71	2.5	2.61	2.03	1.88
Receivables Turnover (Average Receivables)	7.88	9.14	9.08	8.59	9.06
Inventory Turnover (Average Inventory)	5.6	6.76	6.73	6.06	6.07
Short Term Liquidity
Current Ratio	1.72	1.58	1.81	1.77	1.61
Quick Ratio	0.93	0.79	0.96	0.92	0.74
Operating Cash Flow to Current Liabilities	0.56	0.53	0.66	0.52	0.28
Days Sales Outstanding (Average Receivables)	46.45	39.92	40.2	42.49	40.41
Days Outstanding Inventory (Average Inventory)	65.37	53.99	54.22	60.26	60.33
Average Days Payable Outstanding	65.98	56.92	59.49	63.94	60.76
Cash Conversion Cycle (Average Days)	45.83	36.98	34.92	38.82	39.97
Long Term Solvency
Total Debt/Equity	147.84	86.85	78.63	86.19	99
Total Debt / Total Capital	59.65	46.48	44.02	46.29	49.75
LT Debt/Equity	139.87	82.67	73.87	83.42	93.52
Long-Term Debt / Total Capital	56.44	44.24	41.35	44.8	47
Total Liabilities / Total Assets	78.84	70.25	64.94	67.04	68.85
EBIT / Interest Expense	3.2	11.24	9.15	3.53	2.77
EBITDA / Interest Expense	7.64	16.52	15.09	9.08	7.96
(EBITDA - Capex) / Interest Expense	5.96	13.22	11.7	5.48	3.93
Total Debt / EBITDA	3.04	1.35	1.67	2.43	2.74
Net Debt / EBITDA	2.23	1.08	1.18	1.8	2.34
Total Debt / (EBITDA - Capex)	3.9	1.68	2.16	4.03	5.54
Net Debt / (EBITDA - Capex)	2.86	1.35	1.52	2.98	4.74
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-10.27	42.62	3.52	-21.58	-3.72
Gross Profit, 1 Yr. Growth %	-18.09	107.41	-20.53	-40.17	-7.44
EBITDA, 1 Yr. Growth %	-17.83	101.78	-20.35	-39.88	-2.1
EBITA, 1 Yr. Growth %	-27.06	181.27	-25.69	-52.79	-13.8
EBIT, 1 Yr. Growth %	-29.59	209.1	-26.27	-55.58	-14.97
Earnings From Cont. Operations, 1 Yr. Growth %	-175.36	394.98	-27.56	-85.78	81.97
Net Income, 1 Yr. Growth %	-190.14	415.18	-27.4	-87.15	89.47
Normalized Net Income, 1 Yr. Growth %	-39.14	374.57	-32.37	-69.81	-7.67
Diluted EPS Before Extra, 1 Yr. Growth %	-167.23	410.98	-25.06	-86.96	91.52
Accounts Receivable, 1 Yr. Growth %	0.25	33.55	-17.69	-16.4	0.53
Inventory, 1 Yr. Growth %	-8.26	29.31	-5.21	-13.05	7.7
Net Property, Plant and Equip., 1 Yr. Growth %	-4.22	-0.58	-1.36	3.31	3.96
Total Assets, 1 Yr. Growth %	1.56	2.47	-3.79	-4.35	-1.13
Tangible Book Value, 1 Yr. Growth %	-82.25	3.63K	47.73	-18.04	-10.45
Common Equity, 1 Yr. Growth %	-8.17	46.08	14.05	-10.19	-6.73
Cash From Operations, 1 Yr. Growth %	4.99	12.58	6.65	-30.49	-43.92
Capital Expenditures, 1 Yr. Growth %	-31.96	73.56	-6.95	19.75	21.4
Levered Free Cash Flow, 1 Yr. Growth %	-77.55	-3.96	-1.91	-33.86	-104.82
Unlevered Free Cash Flow, 1 Yr. Growth %	-75.6	-4.77	-2.66	-29.48	-87.79
Dividend Per Share, 1 Yr. Growth %	33.33	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-11.85	13.13	21.51	-9.9	-13.11
Gross Profit, 2 Yr. CAGR %	-22.04	30.08	28.38	-31.28	-26.07
EBITDA, 2 Yr. CAGR %	-19.71	28.52	26.77	-31.1	-23.73
EBITA, 2 Yr. CAGR %	-29.13	42.83	44.58	-41.14	-36.71
EBIT, 2 Yr. CAGR %	-31.25	47.07	50.97	-43.15	-39.05
Earnings From Cont. Operations, 2 Yr. CAGR %	-33.66	93.14	89.36	-67.9	-49.12
Net Income, 2 Yr. CAGR %	-48.62	115.5	93.4	-69.45	-50.65
Normalized Net Income, 2 Yr. CAGR %	-40.62	69.34	79.15	-55.15	-47.65
Diluted EPS Before Extra, 2 Yr. CAGR %	-33.91	85.35	95.69	-68.74	-50.02
Accounts Receivable, 2 Yr. CAGR %	-7.03	18.63	4.85	-17.05	-8.32
Inventory, 2 Yr. CAGR %	-9.1	8.92	10.71	-9.21	-3.23
Net Property, Plant and Equip., 2 Yr. CAGR %	1.57	-2.42	-0.97	0.95	3.63
Total Assets, 2 Yr. CAGR %	-14.3	2.02	-0.71	-4.07	-2.75
Tangible Book Value, 2 Yr. CAGR %	-90.25	157.15	641.89	10.03	-14.33
Common Equity, 2 Yr. CAGR %	-38.13	15.82	29.08	1.21	-8.48
Cash From Operations, 2 Yr. CAGR %	20.98	8.72	9.57	-13.9	-37.56
Capital Expenditures, 2 Yr. CAGR %	-21.36	8.67	27.08	5.56	20.57
Levered Free Cash Flow, 2 Yr. CAGR %	-	-53.56	-2.94	-19.84	-82.28
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-51.79	-3.72	-17.52	-70.87
Dividend Per Share, 2 Yr. CAGR %	-	15.47	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-4.12	3.48	9.83	5	-7.88
Gross Profit, 3 Yr. CAGR %	-11.1	8.11	10.37	-0.9	-24.11
EBITDA, 3 Yr. CAGR %	-4.19	9.23	9.57	-1.63	-22.52
EBITA, 3 Yr. CAGR %	-9.44	12.34	14.88	-1.11	-33.13
EBIT, 3 Yr. CAGR %	-10.6	13.63	16.83	-0.3	-34.95
Earnings From Cont. Operations, 3 Yr. CAGR %	0.18	29.64	39.29	-20.1	-42.76
Net Income, 3 Yr. CAGR %	38.11	10.79	49.95	-21.66	-43.87
Normalized Net Income, 3 Yr. CAGR %	-16.82	18.97	24.7	-1.79	-42.9
Diluted EPS Before Extra, 3 Yr. CAGR %	-5.23	30.69	37.06	-20.66	-42.8
Accounts Receivable, 3 Yr. CAGR %	-	6.67	5.02	-2.78	-11.56
Inventory, 3 Yr. CAGR %	-	2.24	3.99	2.15	-3.89
Net Property, Plant and Equip., 3 Yr. CAGR %	-	0.85	-2.06	0.44	1.94
Total Assets, 3 Yr. CAGR %	-	-9.04	0.04	-1.94	-3.1
Tangible Book Value, 3 Yr. CAGR %	-	-29.25	113.77	255.98	2.73
Common Equity, 3 Yr. CAGR %	-	-17.61	15.23	14.38	-1.51
Cash From Operations, 3 Yr. CAGR %	8.1	18.11	8.02	-5.85	-25.36
Capital Expenditures, 3 Yr. CAGR %	-23.55	2.39	3.19	24.59	10.59
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-40.41	-15.15	-68.58
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-39.07	-13.73	-56.36
Dividend Per Share, 3 Yr. CAGR %	-	-	10.06	0	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	0.76	8.77	5.41	-2.09	0.01
Gross Profit, 5 Yr. CAGR %	-6.98	11.67	3.02	-9.93	-5.97
EBITDA, 5 Yr. CAGR %	1.97	24.64	7.21	-9.27	-5.25
EBITA, 5 Yr. CAGR %	-8.29	21.11	9.27	-13.39	-9.55
EBIT, 5 Yr. CAGR %	-10.84	20	10.34	-14	-10
Earnings From Cont. Operations, 5 Yr. CAGR %	-27.58	33.95	29.24	-25.83	-6.9
Net Income, 5 Yr. CAGR %	-28.22	34.53	58.02	-33.82	-3.86
Normalized Net Income, 5 Yr. CAGR %	-26.91	13.69	13.2	-19.6	-11.94
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	26.66	-26.25	-8.45
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-3.54	-0.53
Inventory, 5 Yr. CAGR %	-	-	-	-2.51	1.04
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	0.89	0.18
Total Assets, 5 Yr. CAGR %	-	-	-	-7.08	-1.08
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-15.58	48.28
Common Equity, 5 Yr. CAGR %	-	-	-	-10.55	5.09
Cash From Operations, 5 Yr. CAGR %	-	-	8.69	4.08	-13.25
Capital Expenditures, 5 Yr. CAGR %	-	-	-6.32	3.64	9.82
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-63.34
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	-54.67
Dividend Per Share, 5 Yr. CAGR %	10.76	8.76	-	-	5.92